SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-24
👔
PTC THERAPEUTICS, INC.
@PTCT_InsiderForm 4 Filing: Almstead Neil Gregory Sells $2.5M of $PTCT
INSIDER SALE
⚡ MATERIALITY: 6/10
corporate issuer
PTC THERAPEUTICS, INC.
Ticker: $PTCT
Transaction Value
$2.5M
Price/Share: $53.30
transaction date
2026-06-22
Shares: 47,498
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Almstead Neil Gregory, holds the title of CHIEF TECHNICAL OPS OFFICER at PTC THERAPEUTICS, INC..
On 2026-06-22, the insider transacted 47,498 shares.The shares were transacted at a weighted average price of $53.30 per share, resulting in a total market-relevant value of $2.5M.
Executive Summary Summary
Almstead Neil Gregory (CHIEF TECHNICAL OPS OFFICER) sold $2.5M of $PTCT
Post-Transaction Position: 71,756 shares
SEC Accession No: 0001578850-26-000014 (CIK: 1578850)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.